DynapeniaDDYNAMONCT02437643
An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition
A study testing Weight Loss, Dairy Protein and Low intensity exercise in people with Dynapenia and Obesity, run by Duke University at 1 site in United States.
Trial summary
The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (primarily from dairy and other animal source proteins) with calorie restriction and low-intensity exercise on muscle quality and muscle adipose infiltration (along with bone mineral density [BMD] and a… Read more about this study
- Who is it for?
- Ages 60 years and older
- What is being tested?
- Weight Loss, Dairy Protein and Low intensity exercise
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 81 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Aug 2015to 15 Oct 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- BMI >30;
- SPPB score of ≥4 to <10;
- GFR <45 mL/min
Who cannot join
- Body weight >495 lbs. (BodPod limits);
- estimated glomerular filtration rates (eGFR) less than 45 mL/min;
- symptomatic cardiac disease;
- receiving chemotherapy;
- hemophilia;
- presence of unstable or symptomatic life-threatening illness;
Show all 12Show fewer
- neurological disease or disorder causing functional impairments;
- inability to walk,
- dementia;
- prescription weight loss medications;
- use of monamine oxidase inhibitors (MAOIs); or
- primary medical provider advises against participation.
Trial locations and contacts
1 site in 1 country.
United States1 site
Duke University Medical Center
Durham, North Carolina, 27710
About this study
The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (primarily from dairy and other animal source proteins) with calorie restriction and low-intensity exercise on muscle quality and muscle adipose infiltration (along with bone mineral density [BMD] and a number of secondary outcomes) in frail, obese, older adults participating in a 6 month intervention. The investigators will compare these effects to those of a traditional control regimen of calorie restriction and low-intensity exercise over the same duration.
Read the detailed description
Obese older adults (≥60 yrs) with moderate functional impairment will be randomized to 1 of 2 study arms. Outcomes to be measured at 0, 3 and 6 months are as follows: Primary outcomes- (1) Muscle Quality (MQ): muscle power (time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity) in relation to muscle mass (CT-scan) and (2) Muscle adipose infiltration (MAI) (CT-scan). Secondary outcomes- Bone Mineral Density (BMD; DXA scan) physical function (Short Physical Performance Battery (SPPB); 6 minute walk; 8-foot up and go; and 30 second chair stands; handgrip strength; body weight; fat mass; waist circumference; activity (accelerometers); mental health (sleep, depression, quality of life); and feasibility factors (adherence, protein intake, nutrition adequacy). BMD will only be accessed at 0 and 6 months.
Study Arms:
- Weight loss plus low-intensity exercise intervention (WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, protein~0.8g/g/d. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly. One serving of dairy protein/day will be provided to WL-LoEX participants.
- High protein weight loss plus low-intensity exercise intervention (PRO-WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, with a high proportion of high quality protein at each meal. Intakes of > 30g of protein will be achieved three times a day by subjects in this group, with all or predominantly all from animal sources (high quality) and 60-70% of animal protein from dairy foods that will be provided. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly.
- Being tested
- Weight Loss, Dairy Protein, Low intensity exercise
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Weight LossBehavioural
Participants will be prescribed hypo-caloric diet prescription.
Dairy ProteinDietary supplement
Participants will be provided dairy products: WL-LoEx will be provided 1 dairy serving per day and Pro-WL-LoEx will be provided 8 dairy servings per day.
Low intensity exerciseBehavioural
Participants in both groups will participate in chair exercises 3 times a week.
| Study group | Role | What they receive |
|---|---|---|
| WL-LoEX | Placebo comparator | 10% Weight loss diet plus low intensity exercise (protein ~0.8g/kg). Participants will be provided one serving of dairy protein daily. Receives: Behavioral: Weight Loss; Dietary Supplement: Dairy Protein; Behavioral: Low intensity exercise |
| Pro-WL-LoEX | Active comparator | Protein-enhanced 10% Weight loss diet plus low intensity exercise (protein ~1.2 g/kg with > 30g per meal and >60% as dairy). Participants will be provided at least 8 servings of dairy protein daily. Receives: Behavioral: Weight Loss; Dietary Supplement: Dairy Protein; Behavioral: Low intensity exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in muscle quality
composite score of time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity in relation to muscle mass
Measured: baseline, 3 months, 6 months
Change in muscle adipose infiltration
CT-scan
Measured: baseline, 3 months, 6 months
Secondary outcomes (18)
Change in Physical Function
short physical performance battery score
Measured: baseline, 3 months, 6 months
Change in Body weight
change in weight
Measured: baseline, 3 months, 6 months
Change in lean Body Mass
BodPod
Measured: baseline, 3 months, 6 months
Change in lean Body Mass
DEXA
Measured: baseline, 3 months, 6 months
Change in fat mass
BodPod
Measured: baseline, 3 months, 6 months
Change in fat mass
DEXA
Measured: baseline, 3 months, 6 months
Change in 6-minute walk time
6-minute walk
Measured: baseline, 3 months, 6 months
Change in 8-foot up and go time
time it takes to complete 8-foot up and go
Measured: baseline, 3 months, 6 months
Change in 30 second chair stands
number of chair stands done in 30 seconds
Measured: baseline, 3 months, 6 months
Change in dietary protein intake
3-day food record
Measured: baseline, 3 months, 6 months
Change in calorie intake
3-day food record
Measured: baseline, 3 months, 6 months
Change in Bone Mineral Density
DEXA
Measured: Baseline and 6-months
Change in sleep
Pittsburgh sleep quality index
Measured: baseline, 3 months, 6 months
Change in depression
Center for Epidemiologic Studies Depression Scale
Measured: baseline, 3 months, 6 months
Change in hand grip strength
Jamar Hand Dynamometer
Measured: baseline, 3 months, 6 months
Change in physical activity
Community Health Activities Model Program for Seniors (CHAMPS)
Measured: baseline, 3 months, 6 months
Change in physical activity
Actigraph - accelerometer
Measured: Baseline, 3 months, 6 months
Change in quality of life
SF-36
Measured: Baseline, 3 months, 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2015 (estimated)
- Study start17 Aug 2015
- Primary completion15 Oct 2018
- Study completion15 Oct 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for DynapeniaStudies of the same condition, open and under way.
- More trials run by Duke UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 81 participants (actual)
Sponsor and investigators
- Lead sponsor
- Duke University
- Sponsor type
- University, hospital or other
- Collaborators
- Dairy Research Institute
- Responsible party
- Sponsor
- Investigators
- Connie Bales, PhD, RD, Principal investigator, Duke University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02437643
- Sponsor's protocol ID
- Pro00057509
- Acronym
- DDYNAMO
- Status last verified
- Nov 2018
- First submitted
- 5 May 2015
- Last updated
- 7 Nov 2018
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- Undecided
Publications
Miller MG, Porter Starr KN, Rincker J, Orenduff MC, McDonald SR, Pieper CF, Fruik AR, Lyles KW, Bales CW. Rationale and Design for a Higher (Dairy) Protein Weight Loss Intervention That Promotes Muscle Quality and Bone Health in Older Adults with Obesity: A Randomized, Controlled Pilot Study. J Nutr Gerontol Geriatr. 2021 Apr-Jun;40(2-3):150-170. doi: 10.1080/21551197.2021.1896615. Epub 2021 Mar 13.
PubMed 33719918
Study at a glance
From the registry record, last updated by the sponsor on 7 Nov 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition
- ClinicalTrials.gov ID
- NCT02437643
- Acronym / sponsor ID
- DDYNAMO / Pro00057509
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 81 participants (actual)
- Lead sponsor
- Duke UniversityUniversity, hospital or other
- Collaborators
- Dairy Research Institute
- Study start
- 17 Aug 2015 (actual)
- Primary completion
- 15 Oct 2018 (actual)
- Study completion
- 15 Oct 2018 (actual)
- First posted
- 7 May 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the trial is to assess the effects of combining regular, generous intakes of high quality protein (primarily from dairy and other animal source proteins) with calorie restriction and low-intensity exercise on muscle quality and muscle adipose infiltration (along with bone mineral density [BMD] and a number of secondary outcomes) in frail, obese, older adults participating in a 6 month intervention. The investigators will compare these effects to those of a traditional control regimen of calorie restriction and low-intensity exercise over the same duration.
Detailed description
Obese older adults (≥60 yrs) with moderate functional impairment will be randomized to 1 of 2 study arms. Outcomes to be measured at 0, 3 and 6 months are as follows: Primary outcomes- (1) Muscle Quality (MQ): muscle power (time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity) in relation to muscle mass (CT-scan) and (2) Muscle adipose infiltration (MAI) (CT-scan). Secondary outcomes- Bone Mineral Density (BMD; DXA scan) physical function (Short Physical Performance Battery (SPPB); 6 minute walk; 8-foot up and go; and 30 second chair stands; handgrip strength; body weight; fat mass; waist circumference; activity (accelerometers); mental health (sleep, depression, quality of life); and feasibility factors (adherence, protein intake, nutrition adequacy). BMD will only be accessed at 0 and 6 months.
Study Arms:
- Weight loss plus low-intensity exercise intervention (WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, protein~0.8g/g/d. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly. One serving of dairy protein/day will be provided to WL-LoEX participants.
- High protein weight loss plus low-intensity exercise intervention (PRO-WL-LoEX; n = 35): Subjects follow a calorie-reduction diet for a weight loss of ≥10%, with a high proportion of high quality protein at each meal. Intakes of > 30g of protein will be achieved three times a day by subjects in this group, with all or predominantly all from animal sources (high quality) and 60-70% of animal protein from dairy foods that will be provided. Subjects will also participate in three 30-minute low-intensity exercise sessions weekly.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| WL-LoEX | Placebo comparator | Behavioral: Weight Loss, Dietary Supplement: Dairy Protein, Behavioral: Low intensity exercise10% Weight loss diet plus low intensity exercise (protein ~0.8g/kg). Participants will be provided one serving of dairy protein daily. |
| Pro-WL-LoEX | Active comparator | Behavioral: Weight Loss, Dietary Supplement: Dairy Protein, Behavioral: Low intensity exerciseProtein-enhanced 10% Weight loss diet plus low intensity exercise (protein ~1.2 g/kg with > 30g per meal and >60% as dairy). Participants will be provided at least 8 servings of dairy protein daily. |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- BMI >30;
- SPPB score of ≥4 to <10;
- GFR <45 mL/min
Key exclusion criteria (12 listed)
- Body weight >495 lbs. (BodPod limits);
- estimated glomerular filtration rates (eGFR) less than 45 mL/min;
- symptomatic cardiac disease;
- receiving chemotherapy;
- hemophilia;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Weight LossParticipants will be prescribed hypo-caloric diet prescription. | Behavioural | Pro-WL-LoEX, WL-LoEX |
| Dairy ProteinParticipants will be provided dairy products: WL-LoEx will be provided 1 dairy serving per day and Pro-WL-LoEx will be provided 8 dairy servings per day. | Dietary supplement | Pro-WL-LoEX, WL-LoEX |
| Low intensity exerciseParticipants in both groups will participate in chair exercises 3 times a week. | Behavioural | Pro-WL-LoEX, WL-LoEX |
Primary outcome
Change in muscle quality
Time frame: baseline, 3 months, 6 months
composite score of time to perform ten chair rises, height of the chair, leg length, body mass, and acceleration of gravity in relation to muscle mass
Change in muscle adipose infiltration
Time frame: baseline, 3 months, 6 months
CT-scan
18 secondary outcomes
Change in Physical Function
Time frame: baseline, 3 months, 6 months
Change in Body weight
Time frame: baseline, 3 months, 6 months
Change in lean Body Mass
Time frame: baseline, 3 months, 6 months
Change in lean Body Mass
Time frame: baseline, 3 months, 6 months
Change in fat mass
Time frame: baseline, 3 months, 6 months
Change in fat mass
Time frame: baseline, 3 months, 6 months
Change in 6-minute walk time
Time frame: baseline, 3 months, 6 months
Change in 8-foot up and go time
Time frame: baseline, 3 months, 6 months
Change in 30 second chair stands
Time frame: baseline, 3 months, 6 months
Change in dietary protein intake
Time frame: baseline, 3 months, 6 months
Change in calorie intake
Time frame: baseline, 3 months, 6 months
Change in Bone Mineral Density
Time frame: Baseline and 6-months
Change in sleep
Time frame: baseline, 3 months, 6 months
Change in depression
Time frame: baseline, 3 months, 6 months
Change in hand grip strength
Time frame: baseline, 3 months, 6 months
Change in physical activity
Time frame: baseline, 3 months, 6 months
Change in physical activity
Time frame: Baseline, 3 months, 6 months
Change in quality of life
Time frame: Baseline, 3 months, 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Nov 2018.
- Derived from this study: PubMed 33719918Miller MG, Porter Starr KN, Rincker J, Orenduff MC, McDonald SR, Pieper CF, Fruik AR, Lyles KW, Bales CW. Rationale and Design for a Higher (Dairy) Protein Weight Loss Intervention That Promotes Muscle Quality and Bone Health in Older Adults with Obesity: A Randomized, Controlled Pilot Study. J Nutr Gerontol Geriatr. 2021 Apr-Jun;40(2-3):150-170. doi: 10.1080/21551197.2021.1896615. Epub 2021 Mar 13.
- Individual participant dataSharing planned: Undecided
Related trials for Dynapenia
Not yet recruitingObservational study
Investigation of the Prevalence of Sarcopenia and Dynapenia According to Disease Stage in Patients With Multiple Sclerosis and Evaluation of the Relationship Between Sarcopenia Severity and Clinical and Functional Parameters
Multiple Sclerosis, Sarcopenia
RecruitingObservational study
Patients With Type 2 Diabetes
Diabetes Mellitus Type 2
Not yet recruiting
Blood Flow Restriction Parameters and Lower Limb Function in Older Adults With Dynapenia
Dynapenia
Not yet recruiting
Effectiveness of Whole Body Vibration on Health Outcomes in Older Adults With Dynapenic Abdominal Obesity
Dynapenia, Abdominal Obesity
Enrolling by invitation
Reduction in Resistance Training Volume and Neuromuscular Adaptations in Older Adults
Sarcopenia in Elderly, Dynapenia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Connie Bales, PhD, RD principal investigator
Duke University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Weight Loss, Dairy Protein and Low intensity exercise in people with Dynapenia and Obesity, run by Duke University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in muscle quality (time frame: baseline, 3 months, 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02437643, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2018.